Clinical Trials Browser

Phase 2 × Terminated × farletuzumab × Clear all

NCT01018563 2021-12-08

An Open Label Extension Study of the Efficacy of MORAb-003

Phase 2 Terminated

3 enrolled 12 charts

Carcinoma, Ovarian Epithelial

NCT00738699 2017-03-30

FAR-122

Phase 2 Terminated

415 enrolled 11 charts

Ovarian Neoplasms